Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

PMD

Psychemedics (PMD)

Psychemedics Corporation
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:PMD
일자시간출처헤드라인심볼기업
2024/05/1506:01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PMDPsychemedics Corporation
2024/05/1505:56Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PMDPsychemedics Corporation
2024/05/1505:55GlobeNewswire Inc.Psychemedics Corporation Reports First Quarter 2024 Financial ResultsNASDAQ:PMDPsychemedics Corporation
2024/03/2821:20GlobeNewswire Inc.Psychemedics Corporation Reports 2023 Financial ResultsNASDAQ:PMDPsychemedics Corporation
2024/03/2122:00GlobeNewswire Inc.Psychemedics Recognized as a Top 10 Employee Health Testing Services ProviderNASDAQ:PMDPsychemedics Corporation
2024/02/1323:43Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:PMDPsychemedics Corporation
2024/02/0306:05Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:PMDPsychemedics Corporation
2024/01/2706:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PMDPsychemedics Corporation
2024/01/2507:21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PMDPsychemedics Corporation
2024/01/0301:27GlobeNewswire Inc.Psychemedics Corporation Announces Relocation of Headquarters to Dallas, TexasNASDAQ:PMDPsychemedics Corporation
2023/12/2006:59Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:PMDPsychemedics Corporation
2023/12/1502:56Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:PMDPsychemedics Corporation
2023/11/2801:31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PMDPsychemedics Corporation
2023/11/2723:00GlobeNewswire Inc.Psychemedics Corporation Appoints Daniella Mehalik as VP - FinanceNASDAQ:PMDPsychemedics Corporation
2023/11/1407:16Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PMDPsychemedics Corporation
2023/11/1007:00GlobeNewswire Inc.Psychemedics Corporation Reports Third Quarter 2023 Financial ResultsNASDAQ:PMDPsychemedics Corporation
2023/11/1007:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PMDPsychemedics Corporation
2023/11/0907:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PMDPsychemedics Corporation
2023/10/2800:00GlobeNewswire Inc.Unveiling the Future of Drug Testing: Psychemedics Introduces Advanced 5-Panel Drug ScreenNASDAQ:PMDPsychemedics Corporation
2023/09/2607:29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PMDPsychemedics Corporation
2023/09/2606:53Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:PMDPsychemedics Corporation
2023/09/2302:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PMDPsychemedics Corporation
2023/09/2206:00GlobeNewswire Inc.Psychemedics Corporation Appoints Shannon Shoemaker as Chief Revenue OfficerNASDAQ:PMDPsychemedics Corporation
2023/09/0106:20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PMDPsychemedics Corporation
2023/08/2306:21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PMDPsychemedics Corporation
2023/08/2306:01Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:PMDPsychemedics Corporation
2023/08/2206:48Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PMDPsychemedics Corporation
2023/08/2206:48Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PMDPsychemedics Corporation
2023/08/2206:43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PMDPsychemedics Corporation
2023/08/2206:42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PMDPsychemedics Corporation
 검색 관련기사 보기:NASDAQ:PMD